PsychoGenics

Provides AI-driven preclinical drug discovery for CNS disorders.

Founded 1999 · 124 employees · United States · Private

Funding:

Grant · $3M · 2024

Subsidiaries:

Axelyra, PGI Drug Discovery LLC